Cybrexa Revenue and Competitors
Estimated Revenue & Valuation
- Cybrexa's estimated annual revenue is currently $4.3M per year.
- Cybrexa's estimated revenue per employee is $155,000
Employee Data
- Cybrexa has 28 Employees.
- Cybrexa grew their employee count by 33% last year.
Cybrexa's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Scientific Advisor & Scientific co-founder | Reveal Email/Phone |
2 | Chief Medical Advisor & Scientific co-founder | Reveal Email/Phone |
3 | CFO / COO | Reveal Email/Phone |
4 | VP Clinical Operations | Reveal Email/Phone |
5 | Director, FP&A | Reveal Email/Phone |
6 | Chief Scientific Officer | Reveal Email/Phone |
7 | Director Chemistry | Reveal Email/Phone |
8 | Acting Chief Medical Officer | Reveal Email/Phone |
9 | Sr. Study Manager | Reveal Email/Phone |
10 | Laboratory Manager | Reveal Email/Phone |
Cybrexa Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.2M | 1 | -80% | N/A | N/A |
#2 | $4.3M | 28 | 8% | N/A | N/A |
#3 | $9.8M | 66 | -11% | N/A | N/A |
#4 | $1.4M | 9 | 350% | N/A | N/A |
#5 | $16.6M | 107 | -23% | N/A | N/A |
#6 | $4.5M | 29 | -22% | N/A | N/A |
#7 | $1.7M | 11 | 57% | N/A | N/A |
#8 | $2.3M | 15 | -6% | N/A | N/A |
#9 | $0.3M | 4 | -43% | N/A | N/A |
#10 | $4M | 26 | 0% | N/A | N/A |
What Is Cybrexa?
Cybrexa is a privately-held biotechnology company dedicated to developing next-generation tumor-targeted cancer therapies using its alphalexâ„¢ platform. The Company's lead candidate, CBX-12, an alphalexâ„¢-exatecan conjugate, is expected to enter Phase I in 2021 in advanced solid tumors. Cybrexa also has other preclinical toxin conjugate programs as well as synthetic lethality programs. Cybrexa was founded by physician-scientists and has an experienced management team that has built numerous successful life sciences companies. For more information about Cybrexa, please visit www.cybrexa.com.
keywords:N/A
N/A
Total Funding
28
Number of Employees
$4.3M
Revenue (est)
33%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Cybrexa News
In addition to Cybrexa, Bindra founded Alphina Therapeutics, B3 Therapeutics and Helix Therapeutics, which are all biotechnology companies that...
Other Companies in New Haven
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 28 | 47% | N/A |
#2 | $2.4M | 28 | 33% | N/A |
#3 | $2.9M | 28 | 0% | N/A |
#4 | $3.5M | 28 | 4% | N/A |
#5 | $4.5M | 29 | -22% | N/A |